[Experience of application of hormonal and probiotic therapy in the complex treatment of women in peri- and postmenopausal with chronic recurrent bacterial cystitis in the background of vulvovaginal atrophy] [0.03%]
[激素及益生菌治疗围绝经期和绝经后期合并萎缩性外阴阴道炎反复发作细菌性膀胱炎患者中的应用体会]
A V Kuzmenko,V V Kuzmenko,T A Gyaurgiev
A V Kuzmenko
Introduction: Lower urinary tract infections (LUTI) are one of the most common diseases among women. The risk of LUTI increases with the onset of peri- and postmenopause. Vulvovaginal atrophy occurs in 30% of women aged 5...
[Remote monitoring of urinalysis parametres during treatment of patients with uric acid stones by citrate-containing compounds] [0.03%]
含枸橼酸盐药物治疗尿酸结石患者疗程中远程监测尿液检查指标
M Yu Prosiannikov,I A Shaderkin,O V Konstantinova et al.
M Yu Prosiannikov et al.
Introduction: Oral dissolution therapy has been successfully used in urologic practice since 1950s. However, many doctors attempt to improve efficiency of this approach. Use of different medical personalized digital devic...
[Calcium kidney stones: comparative evaluation of diagnostic value of calcium level in serum, urine and hairs] [0.03%]
高钙尿症肾结石的诊断价值探讨
A A Gres,D M Nitkin,N A Gres et al.
A A Gres et al.
Aim: to study the calcium level in the urine, serum and hairs and to assess the diagnostic value of the calcium level in various biosubstrates in patients with calcium and non-calcium stones. ...
[Clinical value of herbal terpenes after extracorporeal shock-wave therapy] [0.03%]
体外冲击波治疗后中药萜类药物的临床价值评估
V I Rudenko,L M Rapoport,Yu L Demidko et al.
V I Rudenko et al.
Background: Rowatinex is a combined drug based on plant terpenes which provides diuretic, anti-inflammatory and antispasmodic effect. A use of herbal preparation Rowatinex in patients with urinary stone disease after extr...
Clinical Trial
Urologiia (Moscow, Russia : 1999). 2019 Jul:(3):43-49. DOI: 2019
[The experience of using drug Afalaza for treatment of lower urinary symptoms in treatment-nave patients with benign prostatic hyperplasia] [0.03%]
阿伐那非治疗良性前列腺增生症下尿路症状患者的有效性和安全性：前瞻性、多中心真实世界研究
Yu A Kupriyanov,P I Rasner,I M Rokhlikov et al.
Yu A Kupriyanov et al.
Introduction: Benign prostatic hyperplasia (BPH) is one of the most common diseases in men over 50 years. The prevalence of the BPH increases with age, and pathologic features of BPH are found in about 90% of men over 80 ...
Clinical Trial
Urologiia (Moscow, Russia : 1999). 2019 Jul:(3):36-42. DOI: 2019
[Use of cytomedins in case of prostatic involvement in chronic prostatitis according to UPOINT classification] [0.03%]
[根据UPOINT分类慢性前列腺炎伴有前列腺受累时细胞免疫因子的使用]
D V Ergakov,A G Martov,D E Turin
D V Ergakov
Background: chronic prostatitis is a common disease that significantly influence on the quality of life. Aim: Our aim was to assess the...
[Diagnosis and treatment of abacterial category III CP/CPPS, associated with herpes viruses] [0.03%]
[无菌性III型CP/CPPS伴单纯疱疹病毒的诊断与治疗]
V V Evdokimov,V P Kovalyk,V V Malinovskaya et al.
V V Evdokimov et al.
Introduction: The etiology of abacterial CP/CPPS (category III) has not been studied enough. Currently, there is no gold standard of diagnostic study and optimal treatment algorithm. ...
[Prediction of the effectiveness of the therapy of LUTS/BPH by Serenoa repens extracts] [0.03%]
[花粉提取物治疗LUTS/BPH疗效的预测]
A V Sivkov,S A Golovanov,L V Zhukova
A V Sivkov
Introduction: For the treatment of LUTS/BPH is used a wide range of drugs that patients have to take for a long time. Therefore, it is important to develop methods for predicting long-term results of therapy. The purpose ...
D Yu Pushkar,P I Rasner,D V Kotenko et al.
D Yu Pushkar et al.
Introduction: In recent years, there has been a persistent tendency to a decrease in surgical treatment of patients with lower urinary symptoms (LUTS). This fact can be explained by variety drugs which have acceptable saf...